Gilead Sciences Inc. (GILD) News Headlines

▮ More

Date

Headline

8/8/2019 5:23:05 AM DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR

8/6/2019 8:04:36 AM Gilead Canada: Ontario Provides Access To Biktarvy For Treatment Of HIV

7/30/2019 4:26:01 PM Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates

7/30/2019 4:04:22 PM Gilead Sciences Q2 EPS $1.47 Vs. $1.39 Year Ago

7/30/2019 6:06:23 AM Gilead Sciences Q2 19 Earnings Conference Call At 4:30 PM ET

7/29/2019 7:28:28 AM Biotech Stocks Facing FDA Decision In August 2019

7/23/2019 4:14:45 PM Gilead Presents Results From Two Studies Of Investigational TLR7 Agonists

7/23/2019 11:15:40 AM Gilead Presents Findings On Profile Of Descovy For Potential Use As HIV Pre-exposure Prophylaxis Compared With Truvada

7/19/2019 8:53:11 AM Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis

7/19/2019 8:35:35 AM Gilead Sciences Licenses Three Preclinical Antiviral Programs From Novartis

7/17/2019 8:39:14 AM Chief Scientific Officer John McHutchison To Leave Gilead Sciences

7/17/2019 8:37:11 AM Gregg Alton And Katie Watson To Be Departing Gilead

7/17/2019 6:42:46 AM FDA Eliminates REMS For Truvada

7/14/2019 2:16:18 PM Gilead Sciences To Increase Galapagos Stake In $5.1 Bln Deal

7/11/2019 4:39:28 PM Gilead Appoints Christi Shaw As CEO Of Kite

7/11/2019 8:37:27 AM Gilead Sciences, Renown Institute For Health Innovation Announce Collaboration

7/9/2019 12:09:31 AM Lyndra Therapeutics, Gilead Sciences To Collaborate On Development Of Ultra-Long-Acting HIV Therapeutics

7/2/2019 1:45:01 AM Gilead Sciences Plans To Submit NDA For Filgotinib To FDA In 2019

7/2/2019 1:23:35 AM Gilead Sciences Says Path Forward Established To Submit Filgotinib NDA In 2019

6/19/2019 8:34:18 AM Gilead And Nurix Establish Strategic Collaboration To Develop Novel Therapies For Cancer And Other Diseases